What FQHC leaders should know about vision care in 2026

Six planning inputs to check

NACHC's 2025 Vision Services Expansion Brief presents an advocacy estimate. It does not show hiring, service capacity, or outcomes. FY2026 NHSC guidance is dated eligibility context; recheck it for the current cycle. The linked San Ysidro DRES-POCAI source is a published trial protocol without completed results. None of these sources establishes local demand, feasibility, coverage, payment, or return.

California FQHC payment may involve PPS, but the applicable encounter rules, approved scope, site-and-payer rate, coding, authorization, eligibility, denials, collections, and patient-balance treatment must be verified for the proposed workflow. A NACHC advocacy brief describes sector access and capacity; it does not establish a local service-line decision or financial outcome.

• $300 is an editable worksheet illustration—not a floor, conservative input, typical California rate, or payment guarantee. Replace it with the current applicable site-and-payer documentation and test multiple cases.
• 3,600 encounters multiplied by a $300 input equals $1.08M in modeled gross payments. That is arithmetic, not an observed result, capacity target, forecast, or margin; the worksheet omits or simplifies material costs and uncertainties.
• Different retinal-imaging workflows may involve different codes and payer rules. Verify the current CMS fee schedule and each payer's coverage, eligible billing entity, documentation, locality payment, and FQHC treatment; historical fee comparisons do not establish policy intent or return.
• $155,210 — average reported by the ACU 2023 FQHC Optometry Workforce Survey, which had 39 anonymous respondents (about 9% of the workforce). Its rural and urban subgroup averages are descriptive; they do not establish a controlled recruitment premium or a current market rate.
• $47 is a figure reported by CalMatters in April 2026. It does not establish a universal FQHC break-even point, current payer term, or causal explanation for provider participation; verify current contracts and build a site-specific pro forma.
• $630M, 1,070 optometrists, and 10.7 million patients are NACHC advocacy estimates. They are not appropriated funding, observed hiring, delivered services, or projected local outcomes.

Who is not getting eye care

Vision care disparities in California's safety-net population are documented, persistent, and worsening. The CalMatters story in April 2026 made the children's piece impossible to ignore, but the adult and farmworker pictures are equally stark.

Pediatric Medi-Cal: only 16% of California Medi-Cal kids in 2022-24 got an eye exam — down from 19% eight years earlier. 47 of 58 counties got worse. California Education Code §49455 mandates vision screening at K, grades 2, 5, and 8 — but the screening identifies need and the system can't deliver follow-up. Children fail their school screening, get a referral letter, and the referral dies because no provider in their network accepts Medi-Cal.

Latino adults: the Los Angeles Latino Eye Study (LALES) — the foundational NEI population-based study of 6,357 LA Latinos aged 40+ — established that ~50% of Latinos with diabetes have diabetic retinopathy, with >10% having macular edema. 75% of Latinos with open-angle glaucoma or ocular hypertension were UNDIAGNOSED before LALES screening. Most CA FQHCs serve the same population LALES studied. Most don't have routine glaucoma screening protocols built into primary care.

Black adults: the linked Glaucoma Research Foundation summary describes disparities in glaucoma burden and diagnosis. It is not a site-specific screening protocol; clinical owners should use current professional guidance and patient-level risk assessment.

AAPI adults: the linked Glaucoma Research Foundation summary describes population-level glaucoma and myopia context. It does not establish a universal exam protocol; use current clinical guidance and patient-level assessment.

Farmworkers: 38% of US farmworkers report never having visited an eye care professional. Chronic UV exposure, foreign-body trauma, and pesticide exposure compound the need. Migrant Clinicians Network's Puntos de Vista program is the field's playbook for primary eye care delivered by community health workers — but mobile vision capacity to reach the population remains scarce.

The cited population signals justify measuring local need and referral completion. They do not reveal which individual patients were missed, why a referral failed, or which intervention would be safest and most effective at a particular site.

Public program records and their limits

Public pages can confirm that programs, deployments, or protocols exist. They do not establish comparative quality, transferable workflow, causal outcomes, coverage, or financial value. Treat each record as a diligence starting point and review the source boundaries.

• Family Health Centers of San Diego (FHCSD) publicly describes optometry services at multiple locations. Verify the current locations, scope, staffing, language access, capacity, eligibility, and outcomes directly; the page does not establish a model for another FQHC.
• North East Medical Services (NEMS) publicly describes optometry services and language access. Verify the current program and do not infer comparative size, clinical quality, or population outcomes from the service page.
• Alliance Medical Center published information about mobile and fixed-site optometry. That record does not establish statewide uniqueness, reach, outcomes, or compliance for another operator; mobile clinical, licensing, privacy, accessibility, payer, vehicle, and continuity gates remain local.
• The linked DRES-POCAI source describes an 848-participant randomized-trial protocol at two San Ysidro Health sites. It does not report completed results, validate a product for another site, or predict policy, coverage, or capital priorities.
• Tarzana Treatment Centers (LA) — confirmed LumineticsCore deployment. The CA bookend to the Cahaba implementation case study.
• Cahaba Medical Care is described in dated, vendor-authored material from one setting. Its reported workflow and shares must not be extrapolated to another panel or treated as expected diagnostic yield, training time, referral completion, prevented blindness, coverage, or financial value.

Closure, policy, and organization records

Public records can identify a closure, bankruptcy, veto, or dated eligibility rule. They generally cannot prove that a single workforce, payer, funding, or policy factor caused a program outcome. Treat causal explanations as hypotheses requiring organization-level evidence.

• Tiburcio Vasquez Health Center publicly displayed an optometry closure notice when this article was reviewed. That status should be rechecked. The public page does not establish why service changed; payment, workforce, credentialing, demand, capital, leadership, facility, and other explanations require direct evidence.
• Borrego Health filed Chapter 11 in September 2022, and DAP Health acquired the system through bankruptcy court in March 2023. Those records provide organizational context; they do not establish which vision services changed, why, or that vision is universally first at risk. Verify approved scope and current service records.
• AB 2236 vetoed (September 2022) — would have authorized California optometrists to perform therapeutic laser procedures (SLT, peripheral iridotomy, posterior capsulotomy), lesion removal, and corneal crosslinking. Governor Newsom vetoed it, citing insufficient training duration vs ophthalmology residency. The lesson: California has one of the broadest non-surgical OD scopes nationally (post AB 407 + SB 1406) but the surgical-scope ceiling is real. FQHCs that treat OD scope expansion as 'unlimited' are setting up against a regulatory wall. Build referral relationships with ophthalmology partners now.
• FY2026 NHSC guidance is dated eligibility context. Recheck the current cycle, discipline, site, service, HPSA, and application rules; do not infer recruitment or financial outcomes from eligibility alone. The linked AOA material is an advocacy position, not causal workforce evidence.

Cases still in progress

These dated records may inform future evidence or partnership questions. They do not predict a product winner, policy change, partner capacity, or launch decision.

• The linked DRES-POCAI source is a protocol for a planned 848-participant trial at two San Ysidro Health sites. Monitor for completed results and assess methods, version, population, harms, missing data, sponsor role, and applicability before drawing conclusions.
• Vision To Learn and Warby Parker Pupils Project publish organization-reported footprints. Recheck current geography, eligibility, capacity, consent, data terms, accessibility, referral scope, and closed-loop completion; footprint does not establish an FQHC handoff or demand.
• AltaMed has dated public records for ambient documentation and vision services, but this article has no evidence of a vision-AI integration plan. Do not present a speculative next phase as a committed deployment.
• Lions Eye Foundation of CA-NV publishes program information. Verify current eligibility, geography, clinical scope, capacity, referral requirements, wait time, data-sharing, language access, accessibility, and follow-up before relying on it.

Policy and partner records to recheck

The following dates and statuses were reported by linked sources. They are not live guarantees. Confirm the current statute, regulator guidance, program availability, bill status, payer terms, and accountable owner before acting.

• California SB 776 text provides dated mobile-optometry context. Verify current statute, regulations, registration, licensure, facility, vehicle, clinical, privacy, accessibility, payer, continuity, and local requirements. A legal framework and portable device do not establish readiness or an operational pathway.
• VSP Eyes of Hope publishes a request path. Confirm current eligibility, booking window, geography, capacity, terms, data use, accessibility, lead time, and referral responsibilities directly; organization-reported reach does not guarantee availability.
• The linked AOA material describes an advocacy position. Verify the current bill numbers, Congress, committee status, text, agency guidance, and application cycle. Do not infer recruitment outcomes from a proposal.
• CalMatters reported a $47 California Medi-Cal figure in April 2026. Verify current DHCS policy and each contract. Advocacy data should carry methods, dates, denominators, missingness, harms, costs, sponsor relationships, and limits—not an extrapolated vendor-case detection rate.

What FQHC leaders can do this quarter

The public evidence establishes access questions, dated program and policy records, available technologies, and source limitations—not that a vision service line or AI product is clinically appropriate, feasible, covered, payable, or financially valuable at a particular site.

Start with measured patient need and feasible alternatives. Then require verification against current primary sources and accountable clinical, finance, operations, compliance, privacy, security, accessibility, payer, procurement, facilities, referral, patient, and governance sign-off.

Funding, scope, FTCA, NHSC, licensure, credentialing, payer, and employment implications require current owner review. A dated survey, statute, guidance document, or advocacy brief cannot close those gates.

Do not multiply a vendor-authored single-setting Cahaba share by another site's diabetic panel. That would be an unsupported causal extrapolation and could falsely imply detected disease, prevented blindness, demand, or return.

If AI remains in scope, compare the current FDA indication and labeling, independent version-specific evidence, supported hardware, imageability, clinical workflow, staff competency, consent, language access, accessibility, security, privacy, escalation, referral capacity, payer rules, written terms, and total cost. Authorization alone is not adoption evidence.

Use the planning worksheet, AI diligence records, conditional sequence, and dated advocacy tracker as structured prompts. Proceed only after the required local gates close; an explicit no-go or safer alternative is a valid outcome.